Cite
Gene Variants of the OAS/RNase L Pathway and Their Association with Severity of Symptoms and Outcome of SARS-CoV-2 Infection.
MLA
Perez-Favila, Aurelio, et al. “Gene Variants of the OAS/RNase L Pathway and Their Association with Severity of Symptoms and Outcome of SARS-CoV-2 Infection.” Journal of Personalized Medicine, vol. 14, no. 4, Apr. 2024, p. 426. EBSCOhost, https://doi.org/10.3390/jpm14040426.
APA
Perez-Favila, A., Sanchez-Macias, S., De Lara, S. A. O., Garza-Veloz, I., Araujo-Espino, R., Castañeda-Lopez, M. E., Mauricio-Gonzalez, A., Vazquez-Reyes, S., Velasco-Elizondo, P., Trejo-Ortiz, P. M., Montaño, F. E. M., Castruita-De la Rosa, C., & Martinez-Fierro, M. L. (2024). Gene Variants of the OAS/RNase L Pathway and Their Association with Severity of Symptoms and Outcome of SARS-CoV-2 Infection. Journal of Personalized Medicine, 14(4), 426. https://doi.org/10.3390/jpm14040426
Chicago
Perez-Favila, Aurelio, Sonia Sanchez-Macias, Sergio A. Oropeza De Lara, Idalia Garza-Veloz, Roxana Araujo-Espino, Maria E. Castañeda-Lopez, Alejandro Mauricio-Gonzalez, et al. 2024. “Gene Variants of the OAS/RNase L Pathway and Their Association with Severity of Symptoms and Outcome of SARS-CoV-2 Infection.” Journal of Personalized Medicine 14 (4): 426. doi:10.3390/jpm14040426.